Shiro Ikegami

Single-Cell Phosphoproteomics Resolves Adaptive Signaling Dynamics and Informs Targeted Combination Therapy in Glioblastoma.

Paul S Mischel, Timothy F Cloughesy, Kenta Masui, 2016, Cancer cell.

Glucose-dependent acetylation of Rictor promotes targeted cancer therapy resistance

Webster K. Cavenee, William H. Yong, Kenta Masui, 2015, Proceedings of the National Academy of Sciences.

EGFR Mutation Promotes Glioblastoma through Epigenome and Transcription Factor Network Remodeling.

Webster K. Cavenee, Bing Ren, Gary C. Hon, 2015, Molecular cell.